Allen Saliganan

779 total citations
14 papers, 605 citations indexed

About

Allen Saliganan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Allen Saliganan has authored 14 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Allen Saliganan's work include Prostate Cancer Treatment and Research (7 papers), Bone health and treatments (5 papers) and Protease and Inhibitor Mechanisms (4 papers). Allen Saliganan is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Bone health and treatments (5 papers) and Protease and Inhibitor Mechanisms (4 papers). Allen Saliganan collaborates with scholars based in United States, Germany and Qatar. Allen Saliganan's co-authors include Michael L. Cher, R. Daniel Bonfil, M. Katie Conley‐LaComb, Zhiwei Wang, Sanjeev Banerjee, Fazlul H. Sarkar, Yong Q. Chen, Pridvi Kandagatla, Sreenivasa R. Chinni and Shijie Sheng and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Allen Saliganan

14 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allen Saliganan United States 12 275 263 202 181 74 14 605
Gvantsa Kharaishvili Czechia 18 347 1.3× 404 1.5× 153 0.8× 221 1.2× 62 0.8× 26 776
Nikolas G. Balanis United States 12 424 1.5× 425 1.6× 232 1.1× 215 1.2× 100 1.4× 15 822
Fahao Zhang United States 16 310 1.1× 491 1.9× 196 1.0× 124 0.7× 155 2.1× 25 844
Danielle L. Jernigan United States 9 225 0.8× 315 1.2× 103 0.5× 143 0.8× 76 1.0× 11 553
Yunxiao Meng China 17 261 0.9× 510 1.9× 97 0.5× 339 1.9× 70 0.9× 32 909
Fang Zhu China 14 214 0.8× 428 1.6× 112 0.6× 251 1.4× 61 0.8× 41 692
Stina Häggström Rudolfsson Sweden 16 180 0.7× 319 1.2× 338 1.7× 182 1.0× 201 2.7× 22 777
S. Streit Germany 7 364 1.3× 481 1.8× 138 0.7× 130 0.7× 78 1.1× 8 823
Sofia Halin Bergström Sweden 15 181 0.7× 342 1.3× 251 1.2× 171 0.9× 247 3.3× 29 735
Roger S. Jackson United States 11 189 0.7× 392 1.5× 147 0.7× 118 0.7× 55 0.7× 14 620

Countries citing papers authored by Allen Saliganan

Since Specialization
Citations

This map shows the geographic impact of Allen Saliganan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen Saliganan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen Saliganan more than expected).

Fields of papers citing papers by Allen Saliganan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen Saliganan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen Saliganan. The network helps show where Allen Saliganan may publish in the future.

Co-authorship network of co-authors of Allen Saliganan

This figure shows the co-authorship network connecting the top 25 collaborators of Allen Saliganan. A scholar is included among the top collaborators of Allen Saliganan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen Saliganan. Allen Saliganan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sohail, Anjum, R. Daniel Bonfil, Seongho Kim, et al.. (2020). Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts. Scientific Reports. 10(1). 2309–2309. 20 indexed citations
2.
Bonfil, R. Daniel, Anjum Sohail, Semir Vranić, et al.. (2018). Abstract 1070: Discoidin domain receptor 1 (DDR1): A potential suppressor of prostate cancer progression. Cancer Research. 78(13_Supplement). 1070–1070. 1 indexed citations
3.
Dzinic, Sijana H., et al.. (2015). The mouse prostate: a basic anatomical and histological guideline. Bosnian Journal of Basic Medical Sciences. 16(1). 8–13. 69 indexed citations
4.
Zhe, Xiaoning, Jonathan D. Diedrich, Allen Saliganan, et al.. (2014). Bone-induced c-kit expression in prostate cancer: A driver of intraosseous tumor growth. International Journal of Cancer. 136(1). 11–20. 22 indexed citations
5.
Conley‐LaComb, M. Katie, Allen Saliganan, Pridvi Kandagatla, et al.. (2013). PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling. Molecular Cancer. 12(1). 85–85. 123 indexed citations
6.
Huang, Weitong, Yaron Fridman, R. Daniel Bonfil, et al.. (2011). A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth. Oncogene. 31(42). 4527–4535. 28 indexed citations
7.
Najy, Abdo J., Young Suk Jung, M. Katie Conley‐LaComb, et al.. (2011). Cediranib inhibits both the intraosseous growth of PDGF D‐Positive prostate cancer cells and the associated bone reaction. The Prostate. 72(12). 1328–1338. 21 indexed citations
8.
Dong, Zhong, Allen Saliganan, Meng Hong, et al.. (2008). Prostate Cancer Cell-Derived Urokinase-Type Plasminogen Activator Contributes to Intraosseous Tumor Growth and Bone Turnover. Neoplasia. 10(5). 439–449. 37 indexed citations
9.
Osenkowski, Pamela, Huiren Zhao, Márta Tóth, et al.. (2008). The Inactive 44-kDa Processed Form of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Enhances Proteolytic Activity via Regulation of Endocytosis of Active MT1-MMP. Journal of Biological Chemistry. 283(25). 17391–17405. 29 indexed citations
10.
Nabha, Sanaa, Hamilto Yamamoto, Zhong Dong, et al.. (2008). Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP‐12 dependent manner. International Journal of Cancer. 122(11). 2482–2490. 47 indexed citations
11.
Kong, Dejuan, Zhiwei Wang, Sarah Sarkar, et al.. (2008). Platelet-Derived Growth Factor-D Overexpression Contributes to Epithelial-Mesenchymal Transition of PC3 Prostate Cancer Cells. Stem Cells. 26(6). 1425–1435. 119 indexed citations
12.
Wiesner, Christoph, R. Daniel Bonfil, Zhong Dong, et al.. (2007). Heterogeneous Activation of MMP-9 Due to Prostate Cancer-Bone Interaction. Urology. 69(4). 795–799. 15 indexed citations
13.
Banerjee, Sanjeev, Maha Hussain, Zhiwei Wang, et al.. (2007). In vitroandIn vivoMolecular Evidence for Better Therapeutic Efficacy of ABT-627 and Taxotere Combination in Prostate Cancer. Cancer Research. 67(8). 3818–3826. 72 indexed citations
14.
Yamamoto, Hamilto, R. Daniel Bonfil, Christoph Wiesner, et al.. (2006). Quantitative assessment of small intraosseous prostate cancer burden in SCID mice using fluorescence imaging. The Prostate. 67(1). 107–114. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026